These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 375960)

  • 21. Propranolol versus labetalol: interesting differences in efficacy.
    Flamenbaum W
    J Natl Med Assoc; 1985 May; 77 Suppl(Suppl):14-23. PubMed ID: 3889356
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
    Nyberg G; Berglund G
    Acta Med Scand Suppl; 1982; 665():93-101. PubMed ID: 6961763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous nicardipine in Raynaud's phenomenon: a controlled trial.
    van Heereveld H; Wollersheim H; Gough K; Thien T
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):68-74. PubMed ID: 2450259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dilevalol and propranolol on hemodynamics in patients with essential hypertension.
    Hama J; Oda A; Hirano Y; Horiuchi M; Katori R
    Clin Ther; 1991; 13(4):467-70. PubMed ID: 1933998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.
    Lechi A; Pomari S; Berto R; Buniotto P; Parrinello A; Marini F; Cogo L; Tomasi A; Baretta G
    Eur J Clin Pharmacol; 1982; 22(4):289-93. PubMed ID: 7049710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN; Thompson FO; Boakes AJ; Joekes AM
    Clin Sci Mol Med Suppl; 1975 Jun; 2():97s-100s. PubMed ID: 802650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monotherapy with labetalol compared with propranolol. Differential effects by race.
    Flamenbaum W; Weber MA; McMahon FG; Materson BJ; Carr AA; Poland M
    J Clin Hypertens; 1985 Mar; 1(1):56-69. PubMed ID: 3915317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of labetolol and propranolol in patients with untreated hypertension].
    Wessel-Aas T; Walstad RA; Berg KJ
    Tidsskr Nor Laegeforen; 1981 Mar; 101(9-10):579-81. PubMed ID: 7221994
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulatory responses to thiopentone and tracheal intubation in patients with coronary artery disease. Effects of pretreatment with labetalol.
    Fischler M; Dubois C; Brodaty D; Schlumberger S; Melchior JC; Guilmet D; Vourc'h G
    Br J Anaesth; 1985 May; 57(5):493-6. PubMed ID: 3888239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labetalol, a cross-over double blind controlled trial.
    Sanders GL; Routledge PA; Rao JG; Gales GM; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1978 Dec; 14(5):301-4. PubMed ID: 365543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha and beta-blockade and beta-stimulation in Raynaud's syndrome: a double-blind, placebo controlled, single dose study.
    Cleophas TJ; Fennis JF; van 't Laar A
    Angiology; 1985 Apr; 36(4):219-25. PubMed ID: 2862814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
    Tcherdakoff P
    Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.